Eurazeo is continuing to expand its range of funds accessible to individual investors with the launch of Eurazeo Principal Investments fund , mainly intended to be distributed through life insurance contracts (unit-linked), yet also available through direct investment. With this novel arrangement, Eurazeo aims to facilitate the access to professional private equity investments by simplifying the subscription process – particularly via unit-linked life insurance policies – as well as lowering the subscription threshold and allowing savers to invest in a portfolio that is committed from its inception.

As soon as it is launched, the fund will be available at AG2R La Mondiale and at Generali, with a minimum investment of €5,000, and then through life insurance policies in the leading French insurers.

For the first time in the history of private equity funds in France, Investors will be able to subscribe via IZNES, a platform that uses a secure blockchain technology. For subscriptions made via our banking and wealth management partners, the minimum investment amounts to €10,000.

Eurazeo Principal Investments will focus on the buyout and growth investment strategies: the fund will accompany around 30 companies in their growth, particularly in the healthcare, tech and financial services sectors, mainly in Europe, but will also have some exposure to US companies seeking to develop internationally. Just like other Eurazeo Funds that are dedicated to individual investors, Eurazeo Principal Investments will co-invest alongside Eurazeo’s institutional strategies. The fund has obtained the Relance label certification (awarded in France to funds that are supporting the post-Covid recovery of their investees) and allows savers to help finance promising SMEs.

After the recent launch of European Real Estate II ELTIF – a fund offering real estate investments – Eurazeo Principal Investments supplements and enhances Eurazeo’s funds offering to individual investors across all of its investment strategies (private equity, private debt and real estate).

Eurazeo Principal Investments has a target size of €250 million and, thanks to the support of the Eurazeo group, is committed to the following six companies at the time of its launch: Premium, I-Tracing, DiliTrust, Altaïr, Cranial Technologies and Scaled Agile.

For more than 20 years, Eurazeo has been committed to making private equity investment accessible to individual investors, and now manages more than €3 billion of assets for more than 100,000 investors. Eurazeo’s funds intended to individual investors are distributed solely by its banking, insurance and wealth management partners.

Luc Maruenda, Partner, Private Wealth Solutions, said:

“As pioneers of the democratization of private equity we are very happy to announce the launch of this new fund today. This shows our desire to innovate for the benefit of savers. The fund’s units will not be listed but will be available as part of unit-linked life insurance policies, allowing investors to give meaning to their savings by helping the financing of high-potential sectors. By continuing to expand our range, we seek to offer new investment opportunities in buoyant sectors and address all types of investors. For investees, the fund also provides new sources of funding to support their growth.”

Benoit Courmont, member of AG2R La Mondiale’s Group Management Committee in charge of retirement savings and wealth management, added:

“In 2017, we decided to offer the first Eurazeo fund to accessible via life insurance policies. Six years later, the appetite of wealth management clients for this asset class continues to significantly grow. As a result, we had no hesitation in deciding to offer the Eurazeo Principal Investments fund from its inception. We were immediately attracted to the idea of offering our wealth management clients this unprecedented opportunity to benefit from institutional strategies that are already committed to existing buyout transactions.”